论文部分内容阅读
目的：探讨综合治疗对炎性乳腺癌生存率的影响。方法：共收治１８例炎性乳腺癌患者，１１例接受化疗、放疗及手术治疗，４例接受化疗、放疗、手术及内分泌治疗，３例作放疗与化疗。随访时间为６个月～３年。结果：结果显示，６个月、１年、２年及３年总生存率分别为８８．９％（１６／１８）、７３．３％（１１／１５）、５０％（６／１２）、２７．３％（３／１１）。接受综合治疗的患者总生存率为９３．９％（１４／１５）、８４． ６％（１１／１３）、５４．５％（６／１１）、３０％（３／１０）。结论：炎性乳腺癌是最具侵袭性的乳腺肿瘤，也是预后极差的实体肿瘤之一。综合治疗可以改善其总生存率。
Objective: To investigate the effect of comprehensive treatment on the survival rate of inflammatory breast cancer. Methods: A total of 18 patients with inflammatory breast cancer were treated. Eleven patients underwent chemotherapy, radiotherapy and surgery. Four patients underwent chemotherapy, radiotherapy, surgery and endocrine therapy. Three patients underwent radiotherapy and chemotherapy. Follow-up time was 6 months to 3 years. RESULTS: The overall survival at 6 months, 1 year, 2 years, and 3 years was 88.9% (16/18), 73.3% (11/15), 50% (6/12), 27.3% (3/11). Overall survival was 93.9% (14/15) in patients receiving combined treatment, 84. 6% (11/13), 54.5% (6/11), 30% (3/10). Conclusion: Inflammatory breast cancer is the most aggressive breast tumor and one of the most important solid tumors with poor prognosis. Comprehensive treatment can improve its overall survival.